Network
Roger K. Verbeeck
- Queensland University of Technology
- Faculté de Medecine, UCL
- Rhodes University
External person
Pierre Wallemacq
- Université Catholique de Louvain
- Cliniques Universitaires Saint-Luc, Brussels
- Faculté de Medecine, UCL
- Louvain Center for Toxicology and Applied Pharmacology
External person
Pierre E. Wallemacq
- Faculté de Medecine, UCL
- Cliniques Universitaires Saint-Luc, Brussels
External person
Michel Mourad
- Department of Endocrine Surgery
- Université Catholique de Louvain
- Faculté de Medecine, UCL
- Cliniques Universitaires Saint-Luc, Brussels
External person
Kristin E. Karlsson
- European Medicines Agency
- Medical Products Agency
- EMA Modelling and Simulation Working Group
External person
Vincent Haufroid
- Louvain Centre for Toxicology and Applied Pharmacology-Institut de Recherche Expérimentale et Clinique
- Université Catholique de Louvain
- Cliniques Universitaires Saint-Luc, Brussels
- Croix du Sud
- Faculté de Medecine, UCL
External person
Ine Skottheim Rusten
- EMA Modelling and Simulation Working Group
- Norwegian Medicines Agency
- European Medicines Agency
- Systems Resource Lab
External person
Oscar Della Pasqua
- School of Pharmacy
- University College London
- GlaxoSmithKline
- Universiteit Leiden
- Leiden Academic Centre for Drug Research
External person
Arnaud Capron
- Cliniques Universitaires Saint-Luc, Brussels
- Faculté de Medecine, UCL
- Sciensano
External person
Francesco Pappalardo
- Università di Catania
- Menzies Health Institute Queensland
- Boston University
External person
Norbert Benda
- EMA Modelling and Simulation Working Group
- Federal Institute for Drugs and Medical Devices
- European Medicines Agency
- Bundesinstitut fur Arzneimittel und Medizinprodukte
- Germany - BfArM
External person
Joseph Frank Standing
- EMA Modelling and Simulation Working Group
- University College London
- European Medicines Agency
External person
Vanessa Guy-Viterbo
- Cliniques Universitaires Saint-Luc, Brussels
- Louvain Center for Toxicology and Applied Pharmacology
- Faculté de Medecine, UCL
External person
Susan Cole
- EMA Modelling and Simulation Working Group
- Medicines and Healthcare products Regulatory Agency
- European Medicines Agency
External person
Pierre-François Laterre
- Cliniques Universitaires Saint-Luc, Brussels
- Université Catholique de Louvain
- Universitair Ziekenhuis Brussel
- Eli Lilly and Company
- chu Lille
- Faculté de Medecine, UCL
- CHR Mons-Hainaut
External person
Valeria Gigante
- EMA Modelling and Simulation Working Group
- Italy - AIFA
- European Medicines Agency
External person
Marco Viceconti
- Alma Mater Studiorum Università di Bologna
- Rizzoli Orthopaedic Institute
- University of Sheffield
External person
Johannes Taminiau
- EMA Modelling and Simulation Working Group
- Universitair Ziekenhuis Antwerpen
- European Medicines Agency
External person
Françoise Wuillaume
- Université Libre de Bruxelles
- Federal Agency for Medicines and Health Products, Belgium
External person
Gerard Pons
- EMA Modelling and Simulation Working Group
- Université Denis Diderot Paris VII
- European Medicines Agency
External person
Jean-Cyr Yombi
- Université Catholique de Louvain
- Cliniques Universitaires Saint-Luc, Brussels
- Faculté de Medecine, UCL
External person
Rakan Nasreddine
- Centre Hospitalier Universitaire Saint-Pierre
- Université Libre de Bruxelles
External person
Frederike Lentz
- EMA Modelling and Simulation Working Group
- Federal Institute for Drugs and Medical Devices
- European Medicines Agency
- Germany - BfArM
External person
Gaby Wangorsch
- European Medicines Agency
- Paul-Ehrlich-Institut
- EMA Modelling and Simulation Working Group
External person
Francesca Serone
- EMA Modelling and Simulation Working Group
- Italy - AIFA
- European Medicines Agency
External person
Anna Nordmark
- EMA Modelling and Simulation Working Group
- Medical Products Agency
- European Medicines Agency
External person
Justin L. Hay
- EMA Modelling and Simulation Working Group
- Medicines and Healthcare products Regulatory Agency
- European Medicines Agency
External person
Wei Zhao
- EMA Modelling and Simulation Working Group
- Robert Debre University Hospital of Paris
- Shandong University
- European Medicines Agency
External person
Antoine L. Buemi
- Cliniques Universitaires Saint-Luc, Brussels
- Université Catholique de Louvain
- Faculté de Medecine, UCL
External person
Leila Belkhir
- Cliniques Universitaires Saint-Luc, Brussels
- Université Catholique de Louvain
- Faculté de Medecine, UCL
External person
Michiel Van Den Heuvel
- EMA Modelling and Simulation Working Group
- Medicines Evaluation Board, Netherlands
External person
Marc Delforge
- Centre Hospitalier Universitaire Saint-Pierre
- Université Libre de Bruxelles
- University of Copenhagen
External person
Nada Kanaan
- Cliniques Universitaires Saint-Luc, Brussels
- Université Catholique de Louvain
- Faculté de Medecine, UCL
External person
Faustine Lebout
- Université Libre de Bruxelles
- Centre Hospitalier Universitaire Saint-Pierre
External person
Luc De Pauw
- Cliniques Universitaires Saint-Luc, Brussels
- Université Catholique de Louvain
External person
Victor Mangas Sanjuan
- EMA Modelling and Simulation Working Group
- Universidad de Valencia
External person
Piet Hein D. Van Der Graaf
- Leiden Academic Centre for Drug Research
- Certara, United Kingdom
External person
Françoise Van Bambeke
- Louvain Drug Research Institute
- Université Catholique de Louvain
- Faculté de Medecine, UCL
External person
Déborah Konopnicki
- Centre Hospitalier Universitaire Saint-Pierre
- Université Libre de Bruxelles
- Hôpital Erasme, Bruxelles
External person
Loïc Schrooyen
- Centre Hospitalier Universitaire Saint-Pierre
- Université Libre de Bruxelles
External person
Adriana Ceci
- Fondazione per la Ricerca Farmacologica Gianni Benzi onlus
- Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus
External person
Benoît Kabamba-Mukadi
- Croix du Sud
- Cliniques Universitaires Saint-Luc, Brussels
- Faculté de Medecine, UCL
- UCL-CMFA 7340
External person
Essam Kerwash
- EMA Modelling and Simulation Working Group
- Medicines and Healthcare products Regulatory Agency
External person
Randall L. Rasmusson
- Jacobs School of Medicine and Biomedical Sciences
- State University of New York
External person
Julien De Greef
- Université Catholique de Louvain
- Cliniques Universitaires Saint-Luc, Brussels
- Hôpital Henri Mondor
- AP-HP
- CH Jolimont-Lobbes
- Faculté de Medecine, UCL
External person
Michael B. Liu
- University of California Los Angeles
- David Geffen School of Medicine at UCLA
External person
Marie Francoise Vincent
- International Institute of Cellular and Molecular Pathology
- Université Catholique de Louvain
- Cliniques Universitaires Saint-Luc, Brussels
External person
Roger Vanbinst
- Cliniques Universitaires Saint-Luc, Brussels
- Université Catholique de Louvain
External person
Kevin-Alexandre Delongie
- Université Catholique de Louvain
- Cliniques Universitaires Saint-Luc, Brussels
External person
Laure Elens
- Université Catholique de Louvain
- Erasmus University Rotterdam
- Louvain Drug Research Institute
- Cliniques Universitaires Saint-Luc, Brussels
- Croix du Sud
External person
Agnès Libois
- Université Libre de Bruxelles
- Centre Hospitalier Universitaire Saint-Pierre
- Universitat Autònoma de Barcelona (UAB)
- Hospital Clinic Barcelona
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hematopathology Unit, Hospital Clinic, CIBERONC, Barcelona, Spain
External person
Jean Louis Vincent
- Department of Pathology, Erasme Hospital
- Université Libre de Bruxelles
External person
David D. Khan
- EMA Modelling and Simulation Working Group
- Medical Products Agency
- University of Uppsala
External person
Marie-Christine Payen
- Centre Hospitalier Universitaire Saint-Pierre
- Université Libre de Bruxelles
External person